Standard BioTools Inc. (LAB)

Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	51.7	81.31	28.45	68.52	21.66
Short-Term Investments	63.19	84.48	0	0	36.98
Cash & Cash Equivalents	114.9	165.78	28.45	68.52	58.64
Cash Growth	-30.70%	482.70%	-58.48%	16.85%	-38.53%
Receivables	19.66	17.28	18.32	25.42	18.98
Inventory	20.53	21.47	20.83	19.69	13.88
Other Current Assets	3.13	4.28	4.47	4.03	4.59
Total Current Assets	158.22	208.82	72.07	117.66	96.1
Property, Plant & Equipment	54.85	59.54	65.15	55.65	12.92
Goodwill and Intangibles	107.72	118.85	134.31	146.77	150.31
Other Long-Term Assets	2.29	3.11	3.69	4.68	5.49
Total Long-Term Assets	164.85	181.5	203.15	207.09	168.72
Total Assets	323.07	390.31	275.21	324.76	264.81
Accounts Payable	9.24	7.91	10.6	9.22	5.15
Deferred Revenue	29.49	32.61	39.56	45.41	19.97
Current Debt	63.85	5.77	9.89	2.97	1.83
Other Current Liabilities	6.74	-2.85	-10.49	-3.36	5.87
Total Current Liabilities	109.33	43.44	49.57	54.25	32.82
Long-Term Debt	34.36	96.89	101.76	92.4	58.14
Other Long-Term Liabilities	16.18	20.19	29.29	39.06	20.24
Total Long-Term Liabilities	50.54	117.08	131.05	131.46	78.38
Total Liabilities	159.87	160.52	180.62	185.71	111.2
Total Debt	98.21	102.66	111.65	95.38	59.98
Debt Growth	-4.33%	-8.05%	17.06%	59.02%	-65.14%
Retained Earnings	-1,000.75	-926.1	-736	-676.76	-623.64
Comprehensive Income	-2.22	-1.9	-0.91	0.11	-0.58
Shareholders' Equity	-148.05	-81.47	94.6	139.05	153.61
Net Cash / Debt	16.69	63.13	-83.2	-26.86	-1.34
Net Cash / Debt Growth	-73.57%	-	-	-	-
Net Cash Per Share	0.21	0.81	-1.10	-0.37	-0.02
Working Capital	48.89	165.37	22.5	63.41	63.28
Book Value Per Share	-1.87	-1.04	1.25	1.93	2.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).